Elsevier

Current Opinion in Immunology

Volume 54, October 2018, Pages 35-41
Current Opinion in Immunology

Crosstalk between type I and II interferons in regulation of myeloid cell responses during bacterial infection

https://doi.org/10.1016/j.coi.2018.05.014Get rights and content

Highlights

  • Type I and II IFNs have opposing effects in bacterial infections.

  • Type I IFNs dampen inflammatory myeloid cell responses.

  • Suppressive effects of type I IFNs correlate with reduced myeloid cell IFNGR.

  • Abrogating loss of IFNGR improves host resistance to systemic bacterial infection.

Type I and type II interferons (IFNα/β and IFNγ) are cytokines that play indispensable roles in directing myeloid cell activity during inflammatory and immune responses. Each IFN type binds a distinct receptor (IFNAR or IFNGR) to transduce signals that reshape gene expression and function of myeloid and other cell types. In the context of murine models and human bacterial infections, production of IFNγ generally promotes resistance while production of IFNα/β is associated with increased host susceptibility. Here, we review mechanisms of crosstalk between type I and II IFNs in myeloid cells and their impact on myeloid cell activation and anti-microbial function.

Introduction

Cells of the immune system communicate by direct cell-cell interactions and by the release and detection of proteinaceous cytokines and other soluble factors. Interferons (IFNs) are a class of cytokines discovered more than 60 years ago and named for their ability to `interfere' with virus infections [1]. Three distinct IFN types (types I, II, and III) are now recognized based on their ability to bind distinct cognate cell surface receptors [2, 3, 4, 5]. The receptor for each IFN type engages signaling pathways involving Janus kinases and signal transducers and activators of transcription (JAK/STAT). However, the details and outcomes of the signaling engaged by each of the receptors differs. This leads to differential effects on inflammatory and immune responses. Variation in expression of the various IFN receptors also shapes how the IFNs impact immune responses. The receptor for type III IFNs (IFNLR) is selectively expressed on epithelial cells, hepatocytes, and a subset of immune cell types while receptors for type I and II IFNs (respectively IFNAR and IFNGR) are constitutively expressed by nearly all nucleated cells [2, 3, 4, 5]. Variation in the magnitude of IFN receptor expression occurs in different cell types and in response to stimulation. Specifically, expression of the IFNGR changes in myeloid cells exposed to IFNαβ or IFNλ [3,6,7]. These and other mechanisms for crosstalk between the IFNs have the potential to suppress, promote, or tune myeloid cell activation in the context of inflammatory and immune responses. In this review, we summarize differences in type I and II IFNs and their beneficial or harmful effects on the host response to bacterial infections. We further review known mechanisms for crosstalk between these cytokines during bacterial infections and how this influences myeloid cell activity and host resistance, with a focus on the suppressive effects type I IFNs have on myeloid cell accumulation and activation at sites of infection.

Section snippets

Canonical cellular responses to type I and II IFNs

Type I IFNs comprise at least 13 IFNα subtypes, IFNβ, IFNδ, IFNε, IFNκ, IFNτ, and IFNω, the genes for which are clustered on mouse chromosome 4 or human chromosome 9 [8]. Nearly all hematopoietic and non-hematopoietic cell types secrete type I IFN proteins in response to stimuli such as viral and bacterial nucleic acids, cyclic-dinucleotides, or lipopolysaccharide. When secreted IFNs bind the heterodimeric IFNAR, JAK1 and TYK2 tyrosine (Tyr) kinases that are constitutively associated with the

Type I and II IFNs have divergent effects on resistance to many bacterial infections

Despite similarities in the type I and II IFN systems and their common ability to induce a subset of antiviral host genes, these cytokines have opposing effects on resistance to bacterial infection. Defects in the response to IFNγ heightens susceptibility to Mycobacteria, Listeria, and other bacteria [17,18]. Mice whose myeloid cells conditionally lack ifngr1 or express a dominant negative IFNGR rapidly succumb to infection by Lm and other intracellular pathogens [19, 20, 21], further

Type I IFNs suppress myeloid cell accumulation at sites of infection

To engulf and kill microbes, myeloid cells must be appropriately recruited to infection foci. IL-1β and TNFα elicit production of pro-inflammatory chemokines and lipid mediators that can promote such recruitment. Both of these mediators are reportedly elevated in fnar1I−/− mice following infection with Lm or Mtb [30, 31, 32], possibly due to reduced expression of Ch25h and thus sterol-response inhibitory 25-hydroxycholesterol [33]. A recent study further suggested that type I IFN-mediates

IFNγ promotes anti-microbial activation of myeloid cells

Pioneering work by George Mackaness first demonstrated the existence of lymphocyte-derived factors that `activate' macrophages to a state that resists infection by Lm and other pathogenic bacteria [45,46]. Nathan and colleagues subsequently identified IFNγ as the key factor driving this `M1-type' activation [47]. Stimulation of macrophages with IFNγ induces expression of several hundred genes. Many of these GAGs are uniquely or more potently induced by IFNγ versus type I IFNs. Examples include

Type I IFNs inhibit IFNγ-driven activation of myeloid cells

Exposure to microbial products stimulates dendritic cells and some other myeloid cells to release IL-12 and IL-18, which co-stimulate the production of IFNγ by T and innate lymphoid cells. Release of IL-12 and inflammasome activation necessary for IL-18 release can both be inhibited by type I IFNs, potentially reducing IFNγ production during the response to Lm, Mtb, and Staphylococcus aureus [24,30,61]. Though IFNγ still accumulates to stimulatory concentrations in the sera of these infected

Abrogating myeloid cell IFNGR1 reductions improves IFNγ-driven activation and host resistance to bacterial infection

Decreases in myeloid cell surface IFNGR1 staining are preceded by reductions in abundance of ifngr1 transcripts [[70••],64]. The reduced ifngr1 transcripts reflect rapid silencing of de novo transcription at this locus. IFNAR ligation recruits a repressive transcriptional complex to the proximal ifngr1 promoter and promotes histone modifications indicative of transcriptionally inactive chromatin [64]. This transcriptional silencing leads to a rapid reduction in cell surface IFNGR1 protein due

Conclusion

Type I and II IFNs have opposing effects on host resistance to bacterial infection, which correlate with crosstalk between these IFNs. IFNAR ligation suppresses the accumulation of myeloid cells at sites of infection and renders these cells less responsive to IFNγ. Type I IFNs can suppress production of IFNγ by dampening myeloid cell production of IL-12 and act to reduce myeloid cell IFNGR expression. This latter effect renders murine and human myeloid cells less responsive to subsequent

Conflict of interest statement

Nothing declared.

References and recommended reading

Papers of particular interest, published within the period of review, have been highlighted as

  • • of special interest

  • •• of outstanding interest

Acknowledgements

The authors’ work has been funded by research grants from the National Institutes of Health [AI102264, AI103782, AI140499] and the Linda Crnic Institute for Down Syndrome. WJC also received support by a National Institutes of Health Training grant [AI052066]. The sponsors played no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.

References (70)

  • A. Singhal

    Modulation of gamma interferon receptor 1 by Mycobacterium tuberculosis: a potential immune response evasive mechanism

    Infect Immun

    (2007)
  • A. Isaacs et al.

    Virus interference. I. The interferon

    Proc R Soc Lond B Biol Sci

    (1957)
  • E.C. Borden

    Interferons at age 50: past, current and future impact on biomedicine

    Nat Rev Drug Discov

    (2007)
  • N.A. de Weerd et al.

    The interferons and their receptors—distribution and regulation

    Immunol Cell Biol

    (2012)
  • L.C. Platanias

    Mechanisms of type-I- and type-II-interferon-mediated signalling

    Nat Rev Immunol

    (2005)
  • A. Wack et al.

    Guarding the frontiers: the biology of type III interferons

    Nat Immunol

    (2015)
  • M. Rayamajhi

    Induction of IFN-alphabeta enables Listeria monocytogenes to suppress macrophage activation by IFN-gamma

    J Exp Med

    (2010)
  • V. van Pesch

    Characterization of the murine alpha interferon gene family

    J Virol

    (2004)
  • W.M. Schneider et al.

    Interferon-stimulated genes: a complex web of host defenses

    Annu Rev Immunol

    (2014)
  • O.H. Kramer

    A phosphorylation-acetylation switch regulates STAT1 signaling

    Genes Dev

    (2009)
  • F. Antunes et al.

    STAT1 signaling is not regulated by a phosphorylation-acetylation switch

    Mol Cell Biol

    (2011)
  • K. Chen

    Methyltransferase SETD2-mediated methylation of STAT1 is critical for interferon antiviral activity

    Cell

    (2017)
  • S. Liu

    Nuclear RNF2 inhibits interferon function by promoting K33-linked STAT1 disassociation from DNA

    Nat Immunol

    (2018)
  • E. Jouanguy

    A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection

    Nat Genet

    (1999)
  • S.H. Lee

    Identifying the initiating events of anti-Listeria responses using mice with conditional loss of IFN-gamma receptor subunit 1 (IFNGR1)

    J Immunol

    (2013)
  • J.E. Lykens

    Mice with a selective impairment of IFN-gamma signaling in macrophage lineage cells demonstrate the critical role of IFN-gamma-activated macrophages for the control of protozoan parasitic infections in vivo

    J Immunol

    (2010)
  • E.M. Eshleman et al.

    Type I interferons in bacterial infections: taming of myeloid cells and possible implications for autoimmunity

    Front Immunol

    (2014)
  • F. McNab

    Type I interferons in infectious disease

    Nat Rev Immunol

    (2015)
  • C. Manca

    Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway

    J Interferon Cytokine Res

    (2005)
  • R.M. O’Connell

    Type I interferon production enhances susceptibility to Listeria monocytogenes infection

    J Exp Med

    (2004)
  • A. Shahangian

    Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice

    J Clin Invest

    (2009)
  • E.B. Wilson

    Blockade of chronic type I interferon signaling to control persistent LCMV infection

    Science

    (2013)
  • J.R. Teijaro

    Persistent LCMV infection is controlled by blockade of type I interferon signaling

    Science

    (2013)
  • S.A. Stifter

    Functional interplay between type I and II interferons is essential to limit influenza A virus-induced tissue inflammation

    PLoS Pathog

    (2016)
  • V. Auerbuch

    Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes

    J Exp Med

    (2004)
  • Cited by (17)

    • Myeloid cell responsiveness to interferon-gamma is sufficient for initial resistance to Listeria monocytogenes

      2020, Current Research in Immunology
      Citation Excerpt :

      CD4+ T cells thus down regulate IFNGR2 to avoid this IFNγ-driven cell death (Bach et al., 1995; Pernis et al., 1995). The regulation of cellular IFNγ responsiveness impacts host resistance to a number of infectious agents (Crisler and Lenz, 2018). Many questions remain unanswered regarding the regulation of myeloid cell IFNGR expression and activity.

    View all citing articles on Scopus
    View full text